Charles River Laboratories Intl (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Sales | 292,933 | 291,238 | 280,140 | 278,686 | 284,723 |
| Cost of Goods | 190,363 | 187,027 | 189,115 | 185,427 | 181,138 |
| Gross Profit | 102,570 | 104,211 | 91,025 | 93,259 | 103,585 |
| Operating Expenses | 59,745 | 61,475 | 56,071 | 56,004 | 54,449 |
| Operating Income | 43,188 | 42,763 | 35,069 | 37,682 | 49,274 |
| Interest Expense | 7,544 | 8,280 | 8,309 | 8,519 | 8,079 |
| Other Income | 1,203 | 1,165 | -555 | -768 | -1,195 |
| Pre-tax Income | 36,847 | 35,648 | 26,205 | 28,395 | 40,000 |
| Income Tax | 8,219 | 9,722 | 3,488 | 6,011 | 9,453 |
| Net Income Continuous | 28,628 | 25,926 | 22,717 | 22,384 | 30,547 |
| Net Income Discontinuous | -915 | -155 | -4,189 | -182 | 42 |
| Minority Interests | 429 | 193 | 112 | 230 | 121 |
| Net Income | $27,284 | $25,578 | $18,416 | $21,972 | $30,468 |
| EPS Basic Total Ops | 0.57 | 0.54 | 0.39 | 0.46 | 0.63 |
| EPS Basic Continuous Ops | 0.58 | 0.54 | 0.47 | 0.47 | 0.63 |
| EPS Basic Discontinuous Ops | -0.02 | 0.00 | -0.08 | -0.01 | 0.00 |
| EPS Diluted Total Ops | 0.56 | 0.53 | 0.38 | 0.46 | 0.63 |
| EPS Diluted Continuous Ops | 0.58 | 0.53 | 0.47 | 0.46 | 0.63 |
| EPS Diluted Discontinuous Ops | -0.02 | 0.00 | -0.09 | 0.00 | 0.00 |
| EBITDA(a) | $67,736 | $67,330 | $60,213 | $62,706 | $73,656 |